AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.1200
+0.0030 (2.56%)
At close: Sep 22, 2026
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $1.93 million as of September 25, 2026. Its market cap has decreased by -91.30% in one year.
Market Cap
1.93M
Enterprise Value
1.98M
Revenue
98.40K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.12
ChartMarket Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 1.93M, a decrease of -90.55%. That is a compound annual growth rate of -40.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 1.93M | -85.25% |
| Dec 31, 2025 | 13.07M | 157.22% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| International Stem Cell | 2.77M |
| GPL Holdings | 2.56M |
| BioAtla | 2.53M |
| Vaccinex | 2.41M |
| Abpro Holdings | 2.33M |
| Bioxytran | 2.31M |
| VitaSpring Biomedical | 2.30M |
| Enzolytics | 1.93M |